Literature DB >> 180529

Extracytoplasmic adenylate cyclase of Bordetella pertussis.

E L Hewlett, M A Urban, C R Manclark, J Wolff.   

Abstract

Soluble adenylate cyclase [EC 4.6.1.1] accumulates in the culture medium of exponentially growing Bordetella pertussis (300-900 pmol of cAMP formed/min per ml of 24 hr culture supernatant). In addition, there is an extracytoplasmic adenylate cyclase which enables the intact organisms to form [32P] cAMP (adenosine 3':5'-cyclic monophosphate) from exogenous [alpha-32P] ATP (200-1200 nmol of cAMP formed/min per g wet weight of cells) and which comprises 20-45% of the total adenylate cyclase activity. In contrast, only 1.7 and 2.4% of the total cell malate dehydrogenase [EC 1.1.1.37] and alkaline phosphatase [EC 3.1.3.1], respectively, are detectable in the intact cell. Trypsin treatment of intact organisms destroys 96% of the extracytoplasmic adenylate cyclase, but does not reduce the total cell malate dehydrogenase or a small pool of intracellular adenylate cyclase. Four compartments of adenylate cyclase in B. pertussis are proposed; (A) soluble enzyme in the culture supernatant (up to 20% of the total activity); (B) enzyme associated with intact cells and measurable without cell disruption (20-45%); (C) extracytoplasmic enzyme sensitive to trypsin, but not measurable in intact cells at standard substrate concentrations (40-60%); and (D) intracellular enzyme (7-9%). In comparison with previously studied bacterial adenylate cyclases, the extracytoplasmic location appears to be unique to the B. pertussis enzyme.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180529      PMCID: PMC430420          DOI: 10.1073/pnas.73.6.1926

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Interaction of enzyme I of the phosphoenolpyruvate:sugar phosphotransferase system with adenylate cyclase of Escherichia coli.

Authors:  A Peterkofsky; C Gazdar
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

2.  A fine-structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterization of alkaline phosphatase.

Authors:  A GAREN; C LEVINTHAL
Journal:  Biochim Biophys Acta       Date:  1960-03-11

3.  The metabolism of exogenously supplied nucleotides by Escherichia coli.

Authors:  J LICHTENSTEIN; H D BARNER; S S COHEN
Journal:  J Biol Chem       Date:  1960-02       Impact factor: 5.157

4.  The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

Authors:  J M KISSANE; E ROBINS
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

5.  Adenosine 3',5'-cyclic monophosphate in Vibrio cholerae.

Authors:  U Ganguly; W B Greenough
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Adenyl cyclase of Brevibacterium liquefaciens.

Authors:  M Hirata; O Hayaishi
Journal:  Biochim Biophys Acta       Date:  1967-11-21

8.  The release of enzymes by osmotic shock from Escherichia coli in exponential phase.

Authors:  N G Nossal; L A Heppel
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

9.  The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts.

Authors:  H C Neu; L A Heppel
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

10.  Glucose-sensitive adenylate cyclase in toluene-treated cells of Escherichia coli B.

Authors:  J P Harwood; A Peterkofsky
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

View more
  57 in total

1.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Intracellular localization of the dermonecrotic toxin of Bordetella pertussis.

Authors:  J L Cowell; E L Hewlett; C R Manclark
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

4.  Evaluation of a ribosomal vaccine against pertussis.

Authors:  L H Field; C D Parker; C R Manclark; L J Berry
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

5.  Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles.

Authors:  Gina M Donato; Cynthia S Goldsmith; Christopher D Paddock; Joshua C Eby; Mary C Gray; Erik L Hewlett
Journal:  FEBS Lett       Date:  2012-01-28       Impact factor: 4.124

6.  The RNA chaperone Hfq is required for virulence of Bordetella pertussis.

Authors:  Ilona Bibova; Karolina Skopova; Jiri Masin; Ondrej Cerny; David Hot; Peter Sebo; Branislav Vecerek
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

7.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

8.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine.

Authors:  R M Roop; H P Veit; R J Sinsky; S P Veit; E L Hewlett; E T Kornegay
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

10.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.